MEDICA 2022 to Focus on How Health IT Can Contribute to More Sustainability in Health Care
By LabMedica International staff writers Posted on 13 Oct 2022 |

When it comes to current developments within international health IT, there is no way around MEDICA (Düsseldorf, Germany), the world's leading medical trade fair and its accompanying program, which offers further professional insights. Apart from the new products of the more than 4,200 participants from about 70 nations at MEDICA 2022, many of whom showcase health IT solutions, the MEDICA HEALTH IT FORUM, an integrated part of the trade fair, will from 14 to 17 November once more offer an overview of top trends in data-driven medicine, provided by highly acclaimed speakers hosting presentations and talks.
With the “Digital Patient Journey”, for example, an important topic will be presented right at the start of MEDICA 2022 on Monday, 14 November, on the program stage of the MEDICA HEALTH IT FORUM. Moderator Prof. Felix Hoffmann, from the Apollon University for Health Care Management in Bremen, has already emphasized that processes in healthcare need improvements. For example, a fracture of the lateral malleolus (ankle bone) usually would only need standard treatment. But if a patient arrives at the hospital late in the evening, it could happen that rather less experienced doctors have to carry out treatment, according to Hoffmann. In this case, software-based check lists could render valuable support – for example those offered by Kumi Clinical. With the help of this software, clinical teams can plan, organize and synchronize treatment following a digital check list. From their arrival to check-ups in the aftermath of inpatient care, patients follow a digital treatment path, which is based on medical standards (SOPs) and can be flexibly adapted. All roles that share a part of the treatment process are integrated: doctors, care givers, service staff, hospital occupancy and discharge management, as well as medical controlling. This is to ensure that all participants are kept current at all times regarding the latest information, and the entire treatment path is followed correctly. The digital voice recognition software “voize” strives to contribute to the optimization of these processes using digital speech assistants, and will also be represented at this forum's symposium.
In a further symposium on Tuesday afternoon, 15 November, there will be a discussion of therapy plans based on artificial intelligence (AI). Alfa AI, for example, uses AI to create a therapy plan. The inherent intuitive application follows patients throughout the entire process, offers transparency as well as the prescribed training plan, including video lessons. In this way, Alfa AI brings together medical knowledge, long-term experience with sports and fitness, insights about proper nutrition and state-of-the-art technology. There are, however, misgivings concerning “check list medicine”. According to Prof. Felix Hoffmann though, these are more a matter of the proper mindset. “How do I approach treatment?”, “When is a customized form of treatment really necessary?”, and “When can treatments be standardized and carried out following previously defined paths?” are important questions in this context. For Hoffmann who is himself a trauma surgeon, it is a given that digitalization alone does not improve processes. The processes themselves also need improving. As a bad example, he cites the electronic prescription, which would in theory be unnecessary if medicines could be accessed directly, without going through a pharmacy. The pharmacists, however, probably beg to differ on this.
Improving processes in health care could also help fight climate change – for example through beneficial use of information technology. “How can Healthcare become more sustainable with digital help? ” is a question that Armin de Greiff, technical director at the university hospital in Essen will ask during the expert panel at the MEDICA HEALTH IT FORUM on Wednesday, 16 November, which is wholly dedicated to the issue of “Green Health & Sustainability”. “You cannot quite align furthering modern data-driven medicine with saving energy,” states de Greiff. However, he emphasizes that using medical networking does save energy, for example by helping to avoid repeat examinations. Images and findings should not be printed, faxed, sent by post and above all not be transported by taxi. Rather, it should be possible to access them anywhere, at any time.
Armin de Greiff further describes the use of AI for the generation of “virtual contrasts”. With appropriate training, networks are said to be able to predict different contrasts from simple data sets and thus save on time intensive examinations. AI could also help to reduce or eliminate the need for contrast agents during CT examinations. Saving on examination time while reducing radiation and contrast agents could be viewed from a sustainable perspective. On the other hand, this also means, according to de Greiff, that the persistent wish for the newest end user devices runs counter to sustainability. He goes on to explain in this context that the ever shortening product cycles serve to improve performance more than to reduce energy consumption. At the same time, he warns: “We are facing a paradigm shift.” With this, de Greiff calls attention to the fact that higher energy consumption in data centers is not necessarily the same as overall higher consumption of energy. Virtualization of the work place, e.g. through mobile working and by outsourcing applications with high processing demands to servers at a data centre, leads to a concentration of consumption, but not necessarily to raised levels of consumption overall.
Dr. Anna Levsen from the Deutsches Krankenhaus Institut, the German hospital association, also strives to improve processes. Her tech talk centers on “Circularity in the Healthcare Industry” on Wednesday, 16 November at 12:00 noon. Expanding on her presentation at the forum, Levsen calls attention to the strict limitations that hospitals face in their actions for sustainability and protection of the climate. However, she insists: “There is a big lever we can use here.” Levsen, too, sees the more sustainable use of, for example, large equipment as a chance. Outdated technical equipment is rather wholly renewed than repaired and kept in the system, as a circular economy would do. One solution could be a service contract with a manufacturer for medical technology, who could maintain the device in good working order. “Hospitals then would not own a device which they would have to throw away in the end, but they would own a contract according to which the company would provide the device, which would be kept usable as a high-quality product,” Dr. Levsen describes this approach. In this approach, manufacturers of medical technology would retain control over their devices.
There is also room to improve for many hospitals when it comes to food, reducing the number of surplus meals and avoiding waste. From a clinical perspective, technologies used in telemedicine within radiology for example, also offer options to reduce the need for resources. If patients must be taken care of at home while receiving telemedical treatment, they also need the appropriate devices and need training in how to use them – and this is often difficult to achieve as Dr. Levsen summarizes: “A lot of things aren't thought through.” Circular economy means that all processes from beginning to end would have to be thought through, and even single-use products could offer a more sustainable solution than expected, especially where hygiene is an issue. We talk a lot about reducing carbon emissions, but we also have to talk about keeping resources in the system,” Dr. Levsen emphasizes. For her, it is clear: “There is a need for action.” The main hindrance from the perspective of the hospital association are a lack of funds for urgently needed investments to protect the climate, which could also help to make the entire energy and resource cycle more efficient. Considering the current gas crisis, Levsen hopes that this will now set things into motion. Another challenge is to get hospital staff "on board”. As a rule of thumb, about ten percent of energy consumption can be saved by the users. Even taking the stairs instead of the lift or bringing your own coffee cup to work could help save resources. On the final day, 17 November 2022, the forum will focus on general developments and their possible relevance with regard to health IT. Some of the topics in the program are “Gender-sensitive medicine” and “New work & occupational health” as well as new developments in AI.
Related Links:
MEDICA
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more